Chemical Compound Review:
nizatidine (E)-N-[2-[[2- (dimethylaminomethyl)-1,3...
Synonyms:
Calmaxid, Cronizat, Distaxid, Naxidine, Antizid, ...
- Rebound nocturnal hypersecretion after four weeks treatment with an H2 receptor antagonist. Fullarton, G.M., McLauchlan, G., Macdonald, A., Crean, G.P., McColl, K.E. Gut (1989)
- A double-blind, placebo-controlled study of the effectiveness and safety of nizatidine in the prevention of postprandial heartburn. Spiegel, J.E., Thoden, W.R., Pappas, K., Fratarcangelo, P., Furey, S.A. Arch. Intern. Med. (1997)
- Leukocytoclastic vasculitis associated with nizatidine therapy. Suh, J.G., Oleksowicz, L., Dutcher, J.P. Am. J. Med. (1997)
- Negative chronotropic effects of nizatidine. Halabi, A., Kirch, W. Gut (1991)
- Nizatidine prevents peptic ulceration in high-risk patients taking nonsteroidal anti-inflammatory drugs. Levine, L.R., Cloud, M.L., Enas, N.H. Arch. Intern. Med. (1993)
- Obstructive sleep apnea and gastroesophageal reflux. Ing, A.J., Ngu, M.C., Breslin, A.B. Am. J. Med. (2000)
- Extrapyramidal symptoms related to adjunctive nizatidine therapy in an adolescent receiving quetiapine and paroxetine. Bhanji, N.H., Margolese, H.C. Pharmacotherapy (2004)
- Significance of duodenogastric reflux in patients with erosive esophagitis. Simić, A., Pesko, P. Acta chirurgica Iugoslavica. (2000)
- Effect of nizatidine on olanzapine-associated weight gain in schizophrenic patients in Korea: a pilot study. Pae, C.U., Kim, J.J., Lee, K.U., Lee, C.U., Bahk, W.M., Lee, S.J., Lee, C., Paik, I.H. Human psychopharmacology. (2003)
- Risk factors of relapse in gastric ulcer: a one-year, double-blind, comparative study of nizatidine versus placebo. Battaglia, G. The Italian journal of gastroenterology. (1994)
- H(2) antagonist nizatidine may control olanzapine-associated weight gain in schizophrenic patients. Sacchetti, E., Guarneri, L., Bravi, D. Biol. Psychiatry (2000)
- Peptic ulcer in the elderly--a double-blind, short-term study comparing nizatidine 300 mg with ranitidine 300 mg. GISU (Interdisciplinary Ulcer Study Group). Battaglia, G., Di Mario, F., Vigneri, S., Dal Santo, P., Pilotto, A., Mazzacca, G. Aliment. Pharmacol. Ther. (1993)
- Actions of nizatidine, a selective histamine H2-receptor antagonist, on gastric acid secretion in dogs, rats and frogs. Lin, T.M., Evans, D.C., Warrick, M.W., Pioch, R.P. J. Pharmacol. Exp. Ther. (1986)
- Comparison of the efficacy of pantoprazole vs. nizatidine in the treatment of erosive oesophagitis: a randomized, active-controlled, double-blind study. Kovacs, T.O., Wilcox, C.M., DeVault, K., Miska, D., Bochenek, W. Aliment. Pharmacol. Ther. (2002)
- Actions of nizatidine on the rat uterus, dog stomach and experimentally induced gastric lesions. Lin, T.M., Evans, D.C., Warrick, M.W., Ruffolo, R.R. J. Pharmacol. Exp. Ther. (1986)
- Clinical experience with pantoprazole in gastroesophageal reflux disease. Avner, D.L. Clinical therapeutics. (2000)
- Absorption studies of the H2-blocker nizatidine. Knadler, M.P., Bergstrom, R.F., Callaghan, J.T., Obermeyer, B.D., Rubin, A. Clin. Pharmacol. Ther. (1987)
- Intravenous nizatidine kinetics and acid suppression. Callaghan, J.T., Bergstrom, R.F., Obermeyer, B.D., King, E.P., Offen, W.W. Clin. Pharmacol. Ther. (1985)
- Nizatidine disposition in subjects with normal and impaired renal function. Aronoff, G.R., Bergstrom, R.F., Bopp, R.J., Sloan, R.S., Callaghan, J.T. Clin. Pharmacol. Ther. (1988)
- Cimetidine inhibition of human gastric and liver alcohol dehydrogenase isoenzymes: identification of inhibitor complexes by kinetics and molecular modeling. Stone, C.L., Hurley, T.D., Peggs, C.F., Kedishvili, N.Y., Davis, G.J., Thomasson, H.R., Li, T.K., Bosron, W.F. Biochemistry (1995)
- Gastroprokinetic activity of nizatidine, a new H2-receptor antagonist, and its possible mechanism of action in dogs and rats. Ueki, S., Seiki, M., Yoneta, T., Aita, H., Chaki, K., Hori, Y., Morita, H., Tagashira, E., Itoh, Z. J. Pharmacol. Exp. Ther. (1993)
- Secretion of nizatidine into human breast milk after single and multiple doses. Obermeyer, B.D., Bergstrom, R.F., Callaghan, J.T., Knadler, M.P., Golichowski, A., Rubin, A. Clin. Pharmacol. Ther. (1990)
- Carrier-mediated active transport of histamine H2 receptor antagonists, cimetidine and nizatidine, into isolated rat hepatocytes: contribution of type I system. Nakamura, H., Sano, H., Yamazaki, M., Sugiyama, Y. J. Pharmacol. Exp. Ther. (1994)
- Twenty four hour intragastric acidity and plasma gastrin concentration in healthy volunteers taking nizatidine 150 mg, nizatidine 300 mg, ranitidine 300 mg, or placebo at 21:00 h. Lanzon-Miller, S., Pounder, R.E., Chronos, N.A., Raymond, F., Hamilton, M.R., Dalgleish, D. Gut (1988)
- The medical management of reflux esophagitis. Role of antacids and acid inhibition. Sontag, S.J. Gastroenterol. Clin. North Am. (1990)
- Cimetidine uptake and interactions with cationic drugs in freshly isolated proximal tubular cells of the rat. Boom, S.P., Russel, F.G. J. Pharmacol. Exp. Ther. (1993)
- Inhibition of drug metabolism in human liver microsomes by nizatidine, cimetidine and omeprazole. Furuta, S., Kamada, E., Suzuki, T., Sugimoto, T., Kawabata, Y., Shinozaki, Y., Sano, H. Xenobiotica (2001)
- Effects of histamine H(2)-receptor antagonists on human plasma levels of calcitonin gene-related peptide, substance P and vasoactive intestinal peptide. Itoh, H., Naito, T., Takeyama, M. J. Pharm. Pharmacol. (2002)
- H2 histamine receptor blockade in the treatment of Alzheimer disease: a randomized, double-blind, placebo-controlled trial of nizatidine. Carlson, M.C., Tschanz, J.T., Norton, M.C., Welsh-Bohmer, K., Martin, B.K., Breitner, J.C. Alzheimer disease and associated disorders. (2002)
- Head-column field-amplified sample stacking in capillary electrophoresis for the determination of cimetidine, famotidine, nizatidine, and ranitidine-HCl in plasma. Wu, S.M., Ho, Y.H., Wu, H.L., Chen, S.H., Ko, H.S. Electrophoresis (2001)
- A comparison of two doses of nizatidine versus placebo in the treatment of reflux oesophagitis. Quik, R.F., Cooper, M.J., Gleeson, M., Hentschel, E., Schuetze, K., Kingston, R.D., Mitchell, M. Aliment. Pharmacol. Ther. (1990)